BIO-B vs QGEN

Comparison between Bio-Rad Laboratories Inc - Class B (BIO-B, Company) and Qiagen NV (QGEN, Company).

Both BIO-B and QGEN are from the Healthcare sector.

5-Year PerformanceQGEN has outperformed BIO-B, delivering a return of -6.0% compared to -14.8%

BIO-B vs QGEN - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	BIO-B(COMPANY)	QGEN(COMPANY)
Market Cap	$7.21B	$7.24B
Max Drawdown	72.48%	92.14%
Sharpe Ratio	0.26	-0.56
5Y Beta	-0.11	0.52
Industry	Medical Devices	Diagnostics & Research
P/E Ratio	-14.62	17.04
Forward P/E	30.21	11.04
PEG Ratio	1.21	0.04
Dividend Yield	N/A	0.77%
5Y EPS CAGR	N/A	3.15%
Debt to Equity	11.72%	43.79%
Free Cash Flow Yield	4.95%	6.26%
P/S Ratio	2.76	3.45
P/B Ratio	1.04	2.12

Market Cap

BIO-B

$7.21B

Winner

QGEN

$7.24B

Max Drawdown

Winner

BIO-B

72.48%

QGEN

92.14%

Sharpe Ratio

Winner

BIO-B

0.26

QGEN

-0.56

5Y Beta

Winner

BIO-B

-0.11

QGEN

0.52

Industry

BIO-B

Medical Devices

QGEN

Diagnostics & Research

P/E Ratio

Winner

BIO-B

-14.62

QGEN

17.04

Forward P/E

BIO-B

30.21

Winner

QGEN

11.04

PEG Ratio

BIO-B

1.21

Winner

QGEN

0.04

Dividend Yield

BIO-B

N/A

QGEN

0.77%

5Y EPS CAGR

BIO-B

N/A

QGEN

3.15%

Debt to Equity

Winner

BIO-B

11.72%

QGEN

43.79%

Free Cash Flow Yield

BIO-B

4.95%

Winner

QGEN

6.26%

P/S Ratio

Winner

BIO-B

2.76

QGEN

3.45

P/B Ratio

Winner

BIO-B

1.04

QGEN

2.12

BIO-B vs QGEN - Historical Returns

Returns include dividend reinvestment.

Period	BIO-B	QGEN
1 month	-10.69%	-12.01%
3 months	-0.54%	-25.88%
6 months	-13.93%	-25.30%
1 year	+6.94%	-16.89%
5 years(CAGR)	-14.82%	-5.97%
10 years(CAGR)	+6.40%	+5.03%
Max(CAGR)	+12.53%	+3.72%

Winner

BIO-B

-10.69%

QGEN

-12.01%

Winner

BIO-B

-0.54%

QGEN

-25.88%

Winner

BIO-B

-13.93%

QGEN

-25.30%

Winner

BIO-B

+6.94%

QGEN

-16.89%

5Y(CAGR)

BIO-B

-14.82%

Winner

QGEN

-5.97%

10Y(CAGR)

Winner

BIO-B

+6.40%

QGEN

+5.03%

Max(CAGR)

Winner

BIO-B

+12.53%

QGEN

+3.72%

BIO-B vs QGEN - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	BIO-B	QGEN
2026	-13.93%	-22.57%
2025	-4.58%	+1.53%
2024	+1.54%	+1.85%
2023	-20.76%	-13.02%
2022	-44.94%	-8.16%
2021	+25.91%	+4.26%
2020	+54.89%	+55.76%
2019	+60.70%	-0.97%
2018	-3.46%	+9.85%
2017	+30.08%	+9.49%
2016	+33.03%	+4.90%
2015	+14.67%	+18.31%
2014	-2.37%	-0.30%
2013	+15.80%	+26.78%
2012	+6.31%	+28.18%
2011	-9.98%	-30.43%
2010	+6.86%	-13.72%
2009	+31.80%	+30.51%
2008	-30.83%	-19.30%
2007	+28.86%	+34.59%
2006	+28.31%	+25.66%
2005	+14.04%	+6.53%
2004	-2.64%	-11.12%
2003	+36.47%	+118.25%
2002	+32.81%	-72.71%
2001	+103.17%	-46.97%
2000	+36.25%	+68.73%
1999	-0.56%	+41.78%

BIO-B vs QGEN Drawdown Comparison

The maximum drawdown for BIO-B was -72.48%, occurring on Apr 9, 2025. This drawdown has not yet recovered.

The maximum drawdown for QGEN was -92.14%, occurring on Oct 2, 2002. This drawdown has not yet recovered.

The current BIO-B drawdown is -67.33%. The current QGEN drawdown is -38.87%.

Rank	BIO-B	QGEN
#1	-72.48% Sep 10, 2021 - Apr 9, 2025	-92.14% Jul 17, 2000 - Oct 2, 2002
#2	-50.14% Aug 11, 2008 - Apr 20, 2010	-47.30% Mar 10, 2000 - Jul 17, 2000
#3	-35.34% Mar 1, 2000 - Nov 29, 2000	-23.35% Jan 24, 2000 - Feb 3, 2000
#4	-34.33% Jun 19, 2002 - May 20, 2003	-17.37% Dec 13, 1999 - Jan 10, 2000
#5	-31.86% Sep 4, 2018 - Aug 2, 2019	-10.78% Feb 25, 2000 - Mar 6, 2000
#6	-31.00% May 3, 2011 - Jan 9, 2014	-8.82% Nov 11, 1999 - Dec 1, 1999
#7	-27.68% Nov 8, 2007 - Aug 11, 2008	-8.59% Feb 8, 2000 - Feb 18, 2000
#8	-25.78% May 3, 2010 - Mar 7, 2011	-5.12% Jan 10, 2000 - Jan 14, 2000
#9	-23.33% Dec 26, 2003 - Aug 2, 2005	-3.14% Dec 8, 1999 - Dec 13, 1999
#10	-22.65% Feb 1, 2007 - Sep 27, 2007	-2.02% Nov 4, 1999 - Nov 10, 1999
#11	-20.71% May 17, 2002 - Jun 17, 2002	-1.67% Mar 7, 2000 - Mar 9, 2000
#12	-19.75% Feb 18, 2020 - Apr 14, 2020	-0.47% Nov 1, 1999 - Nov 3, 1999
#13	-19.59% Jun 6, 2003 - Dec 26, 2003	N/A
#14	-18.74% Feb 20, 2014 - Mar 12, 2015	N/A
#15	-18.70% Nov 6, 2020 - Feb 12, 2021	N/A